These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30797806)

  • 41. Local delivery polymer provides sustained antifungal activity of amphotericin B with reduced cytotoxicity.
    Haley RM; Zuckerman ST; Gormley CA; Korley JN; von Recum HA
    Exp Biol Med (Maywood); 2019 Apr; 244(6):526-533. PubMed ID: 30897959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
    Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
    Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
    Souza AC; Nascimento AL; de Vasconcelos NM; Jerônimo MS; Siqueira IM; R-Santos L; Cintra DO; Fuscaldi LL; Pires Júnior OR; Titze-de-Almeida R; Borin MF; Báo SN; Martins OP; Cardoso VN; Fernandes SO; Mortari MR; Tedesco AC; Amaral AC; Felipe MS; Bocca AL
    Eur J Med Chem; 2015 May; 95():267-76. PubMed ID: 25827397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cells.
    Staedtke V; Brähler M; Müller A; Georgieva R; Bauer S; Sternberg N; Voigt A; Lemke A; Keck C; Möschwitzer J; Bäumler H
    Small; 2010 Jan; 6(1):96-103. PubMed ID: 19882684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
    Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD
    Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.
    Lewis RE; Wiederhold NP; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2006 Feb; 57(2):288-93. PubMed ID: 16387749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The synergistic fungicidal effect of low-frequency and low-intensity ultrasound with amphotericin B-loaded nanoparticles on C. albicans in vitro.
    Yang M; Xie S; Adhikari VP; Dong Y; Du Y; Li D
    Int J Pharm; 2018 May; 542(1-2):232-241. PubMed ID: 29559330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier.
    Usman F; Khalil R; Ul-Haq Z; Nakpheng T; Srichana T
    AAPS PharmSciTech; 2018 Jul; 19(5):2077-2086. PubMed ID: 29691753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sterculia striata gum as a potential oral delivery system for protein drugs.
    Freitas AAR; Ribeiro AJ; Santos AC; Veiga F; Nunes LCC; Silva DA; Soares-Sobrinho JL; Silva-Filho EC
    Int J Biol Macromol; 2020 Dec; 164():1683-1692. PubMed ID: 32750476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.
    Gupta PK; Jaiswal AK; Asthana S; Teja B V; Shukla P; Shukla M; Sagar N; Dube A; Rath SK; Mishra PR
    Br J Pharmacol; 2015 Jul; 172(14):3596-610. PubMed ID: 25825339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.
    Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ
    Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
    van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
    J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bovine Serum Albumin Nanoparticles Containing Amphotericin B: Characterization, Cytotoxicity and In Vitro Antifungal Evaluation.
    Casa DM; Karam TK; Alves Ade C; Zgoda AA; Khalil NM; Mainardes RM
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10183-8. PubMed ID: 26682465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-biofilm activity of a sophorolipid-amphotericin B niosomal formulation against Candida albicans.
    Haque F; Sajid M; Cameotra SS; Battacharyya MS
    Biofouling; 2017 Oct; 33(9):768-779. PubMed ID: 28946803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
    Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules.
    de Assis DN; Mosqueira VC; Vilela JM; Andrade MS; Cardoso VN
    Int J Pharm; 2008 Feb; 349(1-2):152-60. PubMed ID: 17869460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
    Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
    J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levan-based hydrogels for controlled release of Amphotericin B for dermal local antifungal therapy of Candidiasis.
    Demirci T; Hasköylü ME; Eroğlu MS; Hemberger J; Toksoy Öner E
    Eur J Pharm Sci; 2020 Mar; 145():105255. PubMed ID: 32032777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.